The Last Great Perform: How Andrew Scott’s Ian Charleson Drama Landed at Focus Features

A four festival bidding war just ended, with Focus Features taking the true story of a dying actor’s triumphant final Hamlet into the mid of the fall season.

Word moved fast once the footage started screening for buyers. Focus Features has acquired North American and several international rights to “Elsinore,” the Ian Charleson biopic starring Andrew Scott and Olivia Colman, closing out what insiders describe as a genuinely competitive scramble among multiple studios. That kind of bidding intensity is rare for a modestly budgeted period drama built around a single stage show, but people who saw early cuts kept using the same word: overwhelming. Scott’s work as Charleson, in particular, is already being talked about as a frontrunner in the Best Actor conversation, months before a single festival audience has weighed in.

Luma

The film is directed by Simon Stone, whose credits include “The Daughter” and “The Dig,” and it was written by Stephen Beresford, the playwright and screenwriter behind “Pride.” Production involved a genuinely international consortium: Studiocanal, LD Entertainment, Lucky Red and Magnolia Mae Films all share producing credit, with Studiocanal handling worldwide sales and releasing the film theatrically across the UK, France, Germany, Poland, the Benelux region, Australia and New Zealand, while Lucky Red distributes in Italy. Universal Pictures International will handle Latin America. It is the kind of financing structure that usually signals a film built for critics and festival juries first, box office charts second, though Focus clearly believes it can do both.

The producing team behind that structure is worth noting too. Andrea Occhipinti of Lucky Red, whose credits include “Il Divo” and “Everybody Knows,” produces alongside Gabrielle Tana and Carolyn Marks Blackwood of Magnolia Mae Films, the outfit behind “The Dig” and “Philomena.” Pete Shilaimon and Mickey Liddell of LD Entertainment, whose past work includes “Jackie” and “Anthropoid,” round out the producing group with Stefano Massenzi and Scott himself. It is a lineup with a consistent track record in exactly this lane of prestige, true story filmmaking, which likely helped convince buyers that “Elsinore” was worth fighting over sight partially unseen.

who

For audiences who only know the name in passing, Ian Charleson is most widely remembered as Eric Liddell, the Olympic runner at the center of “Chariots of Fire,” the 1981 film that won the Academy Award for Best Picture. But the role that “Elsinore” is actually built around came nearly a decade later, in 1989, when Charleson stepped into Hamlet at London’s National Theatre while seriously ill with AIDS. He was one of the first public figures in Britain to disclose his diagnosis, at a time when doing so publicly carried real professional and social risk. He died shortly after that run of performances ended, at the age of 40, and his Hamlet has since become something of a legend among British theatergoers who were in the room for it: a performance given under conditions that should have made it impossible, delivered instead with a clarity and control that people who witnessed it still talk about decades later.

That is the story “Elsinore” is telling, not a straightforward biopic cradle to grave, but a tight focus on the final months of Charleson’s life and the specific, almost impossible act of will it took to get that Hamlet onto the stage. Beresford’s script leans into the contradiction at the center of it: an actor facing his own mortality who chooses, deliberately, to spend what time he has left performing one of the most demanding roles in the English language.

Charleson’s career before that run had already been substantial, including acclaimed National Theatre turns in “Guys and Dolls,” “Fool for Love” and “Cat on a Hot Tin Roof” through the 1980s. The Hamlet itself had a strange history before he ever took the part: Richard Eyre’s production originally starred Daniel Day-Lewis, who left the role partway through the run. Charleson stepped in and played Hamlet from early October to mid November of 1989, already seriously ill, and died that January at 40. Colleagues who were there at the time have described a performance so controlled and so precise that audiences who did not already know his diagnosis had no idea anything was wrong. That gap between what was happening to him privately and what he delivered publicly on stage every night is the emotional core the film is built around, and it is exactly the kind of material that tends to reward a lead actor willing to underplay rather than perform grief for the camera.

theory

Scott has spent the last several years building exactly the kind of resume that makes a role like this land differently than it might have a decade ago. He picked up an Emmy nomination and a Golden Globe nomination for “Ripley,” and he earned a BAFTA lead actor nomination for “All of Us Strangers,” a performance that quietly reset expectations for what people thought he was capable of on screen. Earlier this year he starred in the war drama “Pressure,” also released by Focus, which meant the studio already had a working relationship with him before “Elsinore” ever came up for sale.

Beyond acting the role, Scott also produces “Elsinore,” which puts him closer to this project than almost anything else he has done. People who track the awards conversation closely have started describing him as the current frontrunner for Best Actor, a designation that carries real weight this early, before a single public screening. That framing has already put him in the same sentence as Tom Cruise, whose own awards push this year for “Digger” has been treated as a near lock in some circles, which gives the Best Actor race an unusually charged dynamic before either film has even opened. Whether the frontrunner label holds through Venice, Telluride and Toronto season is another matter entirely, but the early read on Scott’s performance has been consistent across the people who have actually seen it.

It also helps that Scott is coming off a genuine hot streak rather than a single strong year. “Ripley,” “All of Us Strangers” and now “Pressure” have each, in different ways, built a case that he is one of the more interesting actors of his generation working in prestige drama, someone who tends to choose roles built around restraint rather than showiness. “Elsinore” asks for exactly that kind of restraint, playing a man who is actively dying while delivering, by every account, the performance of his career within the story. That is a difficult tonal needle to thread on screen, and it is the reason so much of the early conversation around the film has centered on him specifically rather than on the production as a whole.

scope

Colman plays the doctor who treats Charleson through his illness, a supporting role that nonetheless carries the emotional weight of the film’s back half. It is also, in a smaller way, something of a reunion: Scott and Colman previously shared the screen in “Fleabag,” and the two actors working together again under considerably more somber circumstances gives the pairing an extra layer of interest for anyone who followed that show closely.

The ensemble around them is deep. Billie Piper and Johnny Flynn both appear, alongside Luke Thompson, David Dawsonplaying the filmmaker Derek Jarman, Monica Dolan, Matthew Beard, Joe Locke, Georgie Glen, Sadie Soverall, Adeel Akhtar, Dickie Beau, Juliet Stevenson and Peter Mullan. It is a cast built almost entirely from British stage and screen veterans, which fits a film so rooted in London theatre culture, and early word suggests Piper’s performance in particular has caught people off guard.

cin

Stone has built a reputation as a director drawn to grief and endurance rather than spectacle, and both “The Daughter” and “The Dig” bear that out. “The Dig,” in particular, dealt with mortality and the pressure of finishing meaningful work against a ticking clock, which makes him a logical fit for a story like Charleson’s. Early accounts from people who have seen “Elsinore” describe a film less interested in illness as tragedy and more interested in illness as a test of craft and will, which tracks with how Stone has approached his previous work.

The choice to build the film’s climax around an actual theatrical performance, rather than around a hospital bed, also says something about where Stone’s interests lie. Charleson’s Hamlet becomes the film’s real subject, and by all early accounts, that decision pays off.

The Focus Features logo appears in its signature blue on a dark background, highlighting the studio’s distinctive dotted emblem and clean typographic identity. The minimalist presentation reflects the company’s longstanding association with prestige cinema and award-winning independent films.

crunch

Before Focus closed the deal, sources reported that programmers from four of the major fall festivals, Venice, Telluride, Toronto and New York, were all circling the title, with no premiere venue settled at the time. The film has since been confirmed for its debut at the Toronto International Film Festival, which runs from September 10 through September 20 this year at TIFF Bell Lightbox and the Scotiabank Theatre. Toronto has built a strong recent track record for exactly this kind of awards season launch, and having four festivals compete for a title before its premiere venue was even locked is itself a signal of how the film played to the people who saw it early.

Toronto’s own 2026 slate is unusually deep this year, with its competitive Platform section expanding to twelve films for the first time and non-English-language Platform winners now gaining a direct path to Best International Feature Film consideration at the Oscars, a first for the festival. “Elsinore” arrives into that same festival week, which means it will be competing for critical attention against a genuinely crowded field of galas, special presentations and new work from emerging directors, on top of the awards conversation already building around Scott’s performance.

away

Focus has set “Elsinore” for a limited theatrical release beginning November 20, followed by an expansion over Thanksgiving weekend and further widening through December. That release pattern is a deliberate choice, not an afterthought. Last year Focus used the identical Thanksgiving slot for “Hamnet” after that film also premiered at Toronto, and the timing worked: a limited opening builds critical buzz and specialty box office numbers before a wider run coincides with the thick of holiday moviegoing and the start of precursor awards season. Running the same playbook again for “Elsinore” suggests real confidence inside the studio that this film can follow a similar path.

It also places “Elsinore” alongside a genuinely stacked run of Focus releases through the rest of the year, including Robert Eggers’ “Werwulf” on Christmas Day, Paul Greengrass’ “The Uprising,” and Georgia Oakley’s new adaptation of “Sense and Sensibility.” That is a lot of awards real estate for one studio to be chasing at once, and “Elsinore” now sits near the front of that queue.

end

What happens next depends almost entirely on how “Elsinore” plays in front of an actual festival audience rather than the small rooms of buyers and executives who have seen it so far. A strong reception at Toronto would harden Scott’s position in the Best Actor race and give Focus a genuine second awards contender to run alongside its existing fall slate. A quieter response would not sink the film, given the strength of its ensemble and the built in interest in Charleson’s story, but it would soften some of the frontrunner talk currently surrounding it.

Either way, the acquisition itself tells its own story: a period drama about a single theatrical performance, produced through a patchwork of European financiers, drew real competition among major studios on the strength of its lead performance alone. That is not a common outcome in the current distribution market, and it is worth watching how it plays out over the next several weeks of festival coverage.